German Leisure Stock News

Delivery Hero (XTRA:DHER) recently announced improved earnings for the first half of 2025, reporting sales growth to EUR 6,880 million and a reduced net loss, signaling positive financial momentum. This was supported by raised corporate guidance, forecasting a significant revenue increase, fueled by accelerated growth in South Korea. Over the past week, Delivery Hero's stock price moved up by 16%, a notable shift compared to the broader market rise of 1.4%. These earnings announcements and...

Zalando (XTRA:ZAL) observed a notable 10% price increase over the past week, possibly influenced by broader market trends where indices reached new highs amid easing inflation data. The market's 1.4% rise could have provided a supportive backdrop for the company's upward momentum. Although no specific internal events for Zalando were highlighted during this period, external conditions such as a favorable economic climate and robust market sentiment likely contributed to the stock’s...

thyssenkrupp (XTRA:TKA)'s recent earnings announcement highlighted a challenging financial landscape with a third-quarter net loss of EUR 278 million, signaling ongoing pressure despite a reduced net loss from the previous year. The company's revised guidance for fiscal 2024-2025, which included an adjusted EBIT range and a focus on project execution, likely contributed positively to shareholder sentiment. Although the market has been broadly buoyant, with record highs in indices like the...

Trianel Erneuerbare Energien GmbH & Co. KG and ABO Energy announced that Nordex has been selected to supply and install eight N149/5.X wind turbines for the 45.6 MW Tasdorf wind farm in Schleswig-Holstein, Germany, with a 20-year Premium Service agreement included as part of the deal. This commitment underscores both the ongoing demand for Nordex's products and services in the core German market and the company's role in advancing sustainable energy initiatives across the region. To assess...

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Vonovia (XTRA:VNA) just made its first foray into the Australian debt market, issuing a total of AUD 850 million in unsecured bonds split between 7 and 10-year maturities. For investors watching the stock, this strategic move to raise funds in a new currency could be more than mere financial housekeeping. It signals a calculated effort to diversify its funding options and build relationships with global investors. The size and structure of this bond issue, paired with a competitive weighted...

The recent movement in Mercedes-Benz Group (XTRA:MBG) shares might have some investors pausing to reconsider their next move. Even without a headline-grabbing event, small shifts like this can be enough to get people asking whether the market is quietly signaling something about the company’s future prospects or simply moving with broader trends. For those weighing their options, moments like this offer a chance to dig deeper into what the numbers are saying, beyond the headlines or the day’s...

Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won't get...

The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results...

As the European markets grapple with global growth concerns and mixed performances across major indices, investors are increasingly looking for opportunities where stocks might be trading below their estimated value. In such an environment, identifying undervalued stocks can be crucial, as these may offer potential for appreciation when market conditions stabilize or improve.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Unfortunately for some shareholders, the Brockhaus Technologies AG ( ETR:BKHT ) share price has dived 25% in the last...

For many, the main point of investing is to generate higher returns than the overall market. But every investor is...

CeoTronics ( FRA:CEK ) Full Year 2025 Results Key Financial Results Revenue: €55.8m (up 88% from FY 2024). Net income...

Fuchs (XTRA:FPE3) Shares Catch Investor Attention Amid Recent Moves There has not been a single headline-grabbing event behind Fuchs’ (XTRA:FPE3) latest share price moves. Yet these shifts are bound to get investors thinking twice. When a stock stirs curiosity without a clear external catalyst, it can be a sign that the market is quietly reassessing what it’s worth, or that expectations for its future are quietly changing. For Fuchs, a global player in lubricants and specialty chemicals,...

Uniper (XTRA:UN0) has started to catch some investors’ attention lately, not because of breaking news or a major announcement, but simply because of the stock’s recent moves. While there hasn’t been a specific event driving the headlines, even a quiet stretch in the utilities sector can prompt market watchers to ask if the current price action holds any clues about the outlook for shares. Zooming out, it has been a mixed ride for Uniper over the past year. After sliding more than 12% since...

Carl Zeiss Meditec (XTRA:AFX) is making headlines with its upcoming showcase at the European Society of Cataract and Refractive Surgeons (ESCRS) conference, where it will highlight major innovations in ophthalmic workflow technology. Announcing the debut of its fully integrated cataract and glaucoma solutions, along with the newly CE-marked CIRRUS PathFinder, an AI-enabled support tool for clinicians, the company is signaling a renewed push to improve efficiency and patient outcomes in eye...

If you have ever wondered whether now is the time to jump into Bayer stock or wait it out, you are not alone. Bayer has been nothing short of a roller coaster ride for investors. Over the last five years, shares have lost over 40%, a slide that has certainly tested the patience of long-term holders. But zooming in, there is a fresh sense of momentum brewing. The stock is up nearly 10% in the last month, and year to date, it is sitting on an impressive 45.7% gain. The one-year return is still...

Telefónica Deutschland Holding (HMSE:O2D) has caught the attention of investors lately, even without a headline-grabbing event making waves in the market. When a stock moves without an obvious catalyst, it’s natural to wonder whether the market is picking up on subtle signals or simply reassessing the company’s future outlook in light of prevailing trends. For shareholders and potential buyers alike, these quieter moments can actually be just as telling as big announcements. They often prompt...

Volkswagen (XTRA:VOW3) investors may be taking notice as the stock’s recent uptick is catching some attention. There hasn’t been a specific news event or single headline driving the move. Looking at the steady rise over the month, it’s natural to wonder if something is brewing beneath the surface. For those weighing their options, the question is whether this stock’s recent performance is simply a blip or a sign of a bigger story unfolding. In the bigger picture, Volkswagen’s shares have...

Porsche Automobil Holding (XTRA:PAH3) has caught the eye of many investors recently, as share price moves and fundamentals seem to paint a mixed picture. With economic sentiment shifting and the company’s latest financials published, there is reason for both caution and curiosity. For anyone sitting on the fence about PAH3, now feels like a pivotal moment to reconsider where value could emerge. Looking closer at the numbers, Porsche Automobil Holding’s performance over the past year has been...

Merck KGaA recently appointed Dr. David Weinreich as Global Head of R&D and Chief Medical Officer for its Healthcare business sector, bringing over 20 years of experience leading global drug development and approvals at major biopharma firms. Weinreich’s blend of biopharma leadership, entrepreneurial background, and success with both early- and late-stage pipelines positions Merck KGaA to enhance its innovation capabilities and advance its Healthcare portfolio. We’ll examine how Dr...